PNP and cancer: All prepared compoundswere screened for inhibitory activity against recombinant PNP fromthree species (Homo sapiens (hPNP), Mycobacterium tuberculosis (MtPNP),and Plasmodium falciparum (PfPNP)) and were screened on three T-lymphoblastic celllines (CCRF-CEM, MOLT-4, and Jurkat) and three non-T-cell cancer celllines (HL60, HepG2, and HeLa S3).